Sandfire Resources reports growth in Black Butte copper resources and reserves
Sandfire Resources (ASX:SFR) has released an updated pre-feasibility study for its Black Butte Copper Project in Montana, USA.

Finance journalist at Grafa with years of experience covering Asia-Pacific financial markets at S&P Global, Mortgage Ezy, and GMA Network.
Sandfire Resources (ASX:SFR) has released an updated pre-feasibility study for its Black Butte Copper Project in Montana, USA.
Liberty Metals (ASX:LIB) has exercised its option to acquire a 100% interest in a strategically significant portfolio of Brazilian critical minerals projects.
Proteomics International Laboratories (ASX:PIQ) has been granted a US patent for its proprietary blood test, PromarkerEso.
Freightways Group (ASX:FRW) has entered into an agreement to acquire the business and assets of VT Freight Express.
Cedar Woods Properties (ASX:CWP) has upgraded its earnings guidance for FY26, flagging stronger-than-expected conditions.
MetaMask has rolled out native Bitcoin (CRYPTO:BTC) support, marking a major shift for the wallet as it moves beyond its long-standing focus on Ethereum (CRYPTO:ETH) and EVM-based networks.
The update allows users to buy Bitcoin with fiat, transfer BTC on-chain and swap between Bitcoin, EVM assets and Solana (CRYPTO:SOL) directly within the wallet.
Cardone Ventures, the investment firm led by billionaire Grant Cardone and business partners Brandon and Natalie Dawson, has made an unsolicited, non-binding proposal to acquire PetMed Express (NASDAQ:PETS) for $4.25 per share in cash, implying an equity value of around $89 million.
Kraft Heinz (NASDAQ:KHC) named Steve Cahillane as its next chief executive officer, tapping the former Kellanova chief to guide the food giant through its planned separation into two independently traded companies.
Corteva (NYSE:CTVA), the agricultural technology giant, and Hexagon Bio, a biotechnology company focused on nature-derived therapeutics, announced a multi-million-dollar joint venture aimed at accelerating the discovery of new crop protection solutions.
Palvella Therapeutics (NASDAQ:PVLA) said the U.S. Food and Drug Administration has granted Fast Track Designation to QTORIN 3.9% rapamycin anhydrous gel for treating angiokeratomas, a dermatologic condition with no currently approved therapies.